We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Micro-device and Nanoengineered Materials Developed To Treat Cancer and HIV

By Biotechdaily staff writers
Posted on 01 Oct 2007
Using nanotechnology, engineers have developed a small but powerful device capable of enhancing the delivery of drugs to treat life-threatening disorders.

Called an advanced drug delivery system, the innovative device has many capabilities for destroying tumors, kidney stones, and ulcers, and treating cancer and HIV. More...
Nanotechnology works with microscopic particles that are about one-millionth the size of a strand of hair. At about 16 cm3--a volume comparable to that of four kernels of popcorn--the device now in the evaluation phase, is far smaller than similar delivery systems that have been designed by other researchers.

The development effort was led by Dr. Shubhra Gangopadhyay, an electrical and computer engineering professor in the College of Engineering and head of the International Center for Nano/Micro Systems and Nanotechnology at the University of Missouri-Columbia (MO, USA). Similar to other nano/micro-scale devices developed by Dr. Gangopadhyay, this one also operates on a "dual-use” platform, which powers alternative energy and munitions systems for the U.S. military.

By integrating microchip-based technology with nanotechnology, Dr. Gangopadhyay fused both technologies to create a reaction resulting in supersonic shockwaves. For medical purposes, those shockwaves, along with nanoparticles, propagate into the body to make infected cells permeable for drug interaction. The device allows for a non-invasive procedure that utilizes the body's pores as entry points.

Other usages include the dispersion of drug-carrying nanoparticles, known as a nanosponge, into the body. Such sponges can target specific cells and areas that have been affected by disease. Other applications involve the delivery of gold nanoparticles, a florescent material, into the body. By attaching to infected cells, the unique particles can allow clinicians to track drug movement and the spread of disease throughout the body.

The researchers reported that nanoparticles contain no harmful components and are not hazardous to the body. They also stressed that the device will require as many as three more years of assessment before it is made available to pharmaceutical companies. Nems/Mems Works, LLC will market the device and various nanoparticles associated with the research.


Related Links:
University of Missouri-Columbia

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.